Chapter 8: Reproductive Technology – IVF, Surrogacy & Cloning Ethics

Assisted Reproductive Technology (ART) provides solutions for infertility, fundamentally reshaping human procreation by separating genetic, gestational, and social parenthood and introducing profound moral dilemmas in bioethics. The core method, In Vitro Fertilization (IVF), involves hormonal stimulation, egg retrieval, laboratory fertilization (sometimes using ICSI), embryo culture, and often Preimplantation Genetic Diagnosis (PGD) before uterine transfer. IVF procedures, despite helping millions, are debated due to high costs, varied success rates, and potential health risks to mothers (like Ovarian Hyperstimulation Syndrome) and children (especially risks associated with multiple pregnancies). Ethical consideration is paid to the disposition of unused, cryopreserved embryos and the morality of using PGD to create savior siblings. The chapter also analyzes surrogacy, distinguishing between traditional arrangements (where the surrogate is the genetic mother) and gestational surrogacy (where she is only the carrier), addressing the legal and ethical conflict of commercial agreements often labeled as baby-selling. Finally, the debate covers reproductive cloning, utilizing techniques like Somatic Cell Nuclear Transfer (SCNT) to produce a genetic duplicate. Opponents cite the safety risks and the potential violation of the clone's right to a unique identity or an open future, fears rooted in the misconception of genetic determinism. Proponents counter these claims by appealing to the fundamental right of procreative liberty and the potential for medical or personal benefits, while ethical theories like Utilitarianism, Kantianism, and Natural Law offer diverse frameworks for assessing the moral acceptability of these rapidly evolving reproductive choices.